{"calculatePct":false,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"714"},{"groupId":"OG001","value":"710"}]}],"title":"Grade 0"},{"categories":[{"measurements":[{"groupId":"OG000","value":"727"},{"groupId":"OG001","value":"559"}]}],"title":"Grade 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"171"},{"groupId":"OG001","value":"113"}]}],"title":"Grade 2"},{"categories":[{"measurements":[{"groupId":"OG000","value":"61"},{"groupId":"OG001","value":"22"}]}],"title":"Grade 3"},{"categories":[{"measurements":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"2"}]}],"title":"Grade 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"75"},{"groupId":"OG001","value":"34"}]}],"title":"Missing"}],"denoms":[{"counts":[{"groupId":"OG000","value":"1761"},{"groupId":"OG001","value":"1440"}],"units":"Participants"}],"description":"ECOG-PS measured on-therapy (time between first dose and last dose date with a 30-day lag) assessed participant's performance status on 6 point scale: 0=Fully active/able to carry on all pre-disease activities without restriction; 1=restricted in physically strenuous activity, ambulatory/able to carry out light or sedentary work; 2=ambulatory (\\>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair \\>50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. The line of Therapy was determined at study entry.","groups":[{"description":"Participants newly diagnosed with MM within 3 months from initiation of treatment were enrolled for 3 years, and followed for at least 2 years, until death, or the end of the study, whichever comes first (up to approximately 5 years).","id":"OG000","title":"NDMM"},{"description":"Participants diagnosed with RRMM who previously received 1 to 3 prior lines of therapy were enrolled for 3 years, and followed for at least 2 years, until death, or the end of the study, whichever comes first (up to approximately 5 years).","id":"OG001","title":"RRMM"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"All Enrolled Population included all participants who signed informed consent. Overall number of participants analyzed is the number of participants available for analysis.","reportingStatus":"POSTED","timeFrame":"At Baseline","title":"Number of Participants With ECOG (Eastern Cooperative Oncology Group) Performance Status","type":"PRIMARY","unitOfMeasure":"Participants"}